Strategic Partnerships Leverage the ongoing collaboration with Cleveland Clinic to position your organization as a preferred supplier or co-development partner for neuromodulation devices, rehab integration, and regulatory support in post-stroke recovery programs.

Clinical Trial Growth Target opportunities around RESTORE and future pivotal studies by offering trial equipment, data analytics, real-world evidence solutions, and adaptive study design services to accelerate enrollment and outcomes reporting.

Funding Milestones Capitalize on recent Series B1 funding and high-profile support to present enterprise-grade manufacturing, supply chain scalability, and post-market service packages to potential investors, distributors, and health systems evaluating DBS therapies.

Regulatory Ready Solutions Position as a partner for FDA/CE pathways, quality management, and safety/compliance documentation to support the company’s clinical-stage status and potential expansion into new markets or reimbursement environments.

Market Expansion Fit Outline a go-to-market strategy targeting large medical device players with complementary portfolios (neuromodulation, rehab devices, stroke care) to explore collaboration, licensing, or co-commercialization that accelerates scale.